Arkema AI Stock Analysis
Want to see FR:AKE full AI Analyst Report?
Arkema (AKE) AI Stock Analysis
Arkema
(Paris:AKE)
The score is held back primarily by weak profitability/returns and higher leverage despite the strong TTM revenue rebound, alongside a very high P/E that adds valuation risk. Technicals are mildly supportive with price above key moving averages, but momentum indicators are mixed and do not offset the fundamental and valuation headwinds.
Arkema (AKE) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 4.44B
- Dividend Yield
- 6.13%
- Average Volume (3M)
- 184.90K
- Price to Earnings (P/E)
- 53.4
- Beta (1Y)
- 1.48
- Revenue Growth
- -1.70%
- EPS Growth
- -42.07%
- Country
- France
- Employees
- 20,700
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Arkema Business Overview & Revenue Model
Company Description
Arkema S.A. operates as a global producer and distributor of specialty chemicals and advanced materials. Its operations are strategically divided into four key business segments: Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermed...
How the Company Makes Money
Arkema makes money primarily by manufacturing and selling specialty chemical products and materials to industrial customers, generating revenue through product sales contracts and recurring demand tied to customers’ manufacturing volumes. Its main re...
Arkema Financial Statement Overview
Summary
Revenue rebounded strongly (+37% TTM), but profitability is very weak with net margin around ~0.7% and lower gross/EBIT/EBITDA margins versus 2022–2024. Leverage has increased (debt-to-equity ~0.85 TTM) while returns have deteriorated (ROE ~1%). Cash flow is still positive (FCF ~€373M TTM) but trending weaker with softer conversion.
Income Statement
46NeutralBalance Sheet
62PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.90B | 9.07B | 9.54B | 9.51B | 11.55B | 9.52B |
| Gross Profit | 1.59B | 1.61B | 1.94B | 1.96B | 2.58B | 2.14B |
| EBITDA | 1.23B | 1.25B | 1.31B | 1.33B | 1.98B | 2.54B |
| Net Income | 60.00M | 63.00M | 354.00M | 402.00M | 965.00M | 1.31B |
Balance Sheet | ||||||
| Total Assets | 14.17B | 14.24B | 15.21B | 14.52B | 13.51B | 12.30B |
| Cash, Cash Equivalents and Short-Term Investments | 1.47B | 2.20B | 2.01B | 2.04B | 1.59B | 2.29B |
| Total Debt | 4.27B | 5.36B | 4.55B | 4.28B | 3.26B | 2.76B |
| Total Liabilities | 7.21B | 8.01B | 7.45B | 7.06B | 6.17B | 5.95B |
| Stockholders Equity | 6.78B | 6.04B | 7.53B | 7.20B | 7.30B | 6.30B |
Cash Flow | ||||||
| Free Cash Flow | 372.50M | 337.00M | 353.00M | 622.00M | 766.00M | 152.00M |
| Operating Cash Flow | 915.60M | 973.00M | 1.12B | 1.26B | 1.50B | 915.00M |
| Investing Cash Flow | -535.60M | -616.00M | -940.00M | -1.35B | -2.34B | 473.00M |
| Financing Cash Flow | -220.60M | -262.00M | -207.00M | 516.00M | 168.00M | -652.00M |
Arkema Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Positive. The current price of 58.70 is above the 20-day moving average (MA) of 56.33, above the 50-day MA of 56.38, and above the 200-day MA of 56.95, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 63.41 is Neutral, neither overbought nor oversold. The STOCH value of 59.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:AKE.
Arkema Peers Comparison
Overall Rating
FR:AI63Neutral
FR:AKE54Neutral
FR:ALCRB46Neutral
FR:ALAFY35Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | EUR 121.23B | 32.90 | 13.42% | 1.59% | -1.30% | 3.05% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | EUR 4.44B | 53.36 | 1.28% | 6.13% | -1.70% | -42.07% | |
| 46Neutral | EUR 85.86M | -4.12 | -10.62% | ― | ― | ― | |
| 35Underperform | EUR 86.25M | -11.27 | -7.49% | ― | -13.62% | 54.46% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:AKE | Arkema SA (UK) | 58.70 | 8.39 | 16.68% | |
| FR:AI | Air Liquide (UK) | 192.16 | 38.01 | 24.66% | |
| FR:ALCRB | Carbios SA | 4.90 | -3.75 | -43.35% | |
| FR:ALAFY | AFYREN | 2.23 | -0.17 | -7.29% | |
| FR:ALDUB | Encres Dubuit SA | 1.84 | -0.48 | -20.69% | |
| FR:MLPRX | Parx Materials NV | 0.40 | 0.15 | 60.00% |
Arkema Corporate Events
Arkema’s Specialty Materials Drive Third-Quarter Growth
Arkema, a specialty chemicals producer focused on advanced materials and applications in growth markets, reported stronger third-quarter results despite generally weak demand. Revenue rose 8.1% to €2.4 billion, while EBITDA increased 7.0% to €332 mil...
Arkema Wins Validation for 2035 and 2050 Climate Targets
Arkema develops specialty materials, including adhesives, advanced materials and coating solutions, with a focus on sustainable applications in energy, water, recycling, urbanization and mobility. The Group operates in about 55 countries and aims to...
Arkema Employees Boost Stake in €45 Million Share Issue
Arkema has completed its tenth employee share capital increase since its listing 20 years ago, with nearly 34% of group employees participating and total subscriptions of about €45 million, resulting in new shares equivalent to 1.3% of the company’s...
Arkema boosts low-carbon acrylic leadership with major Carling investment
Arkema has inaugurated a new acrylic acid purification unit at its Carling site in France, using an innovative process that improves energy efficiency by 25% and cuts the site’s carbon intensity by 20%. The nearly €150 million investment, partly fund...
Arkema Reports Share Buyback Transaction on Euronext Paris
Arkema disclosed that it executed a share repurchase operation on 28 September 2026, buying 3,300 of its own shares on the Euronext Paris market at a daily weighted average price of €56.4598. The transaction was carried out under the conditions of Ar...
Arkema Updates Share Capital and Voting Rights Structure as of September 2026
Arkema has reported that as of September 30, 2026, the company has 76,060,831 shares outstanding, with a total of 95,372,290 voting rights when including treasury shares. When excluding shares held by the company itself, the total number of voting ri...
Arkema Boosts Global Battery R&D With €10 Million Expansion in France
Arkema is a global specialty materials company that develops advanced materials, adhesive solutions and coating solutions for high-growth sectors including new energies, water treatment, recycling and sustainable mobility. With a diversified portfoli...
Arkema Discloses Late-September Share Buybacks on Euronext Paris
Arkema reported a series of share buyback transactions carried out between 21 and 25 September 2026 on Euronext Paris, repurchasing a total of 17,600 shares at a weighted average price of about €56.85. The operations, disclosed under EU market abuse...
Arkema strengthens specialty materials push with new deputy CEO for polymers and gases
Arkema has appointed François Desné as Deputy Chief Executive Officer of High Performance Polymers and Fluorinated Gases and member of the Group Executive Committee, effective October 12, 2026. He replaces Laurent Tellier, who became Chief Operating...
Arkema Discloses September 2026 Share Buyback Transactions on Euronext Paris
Arkema has disclosed a new series of share buyback transactions carried out on the Euronext Paris market between 14 and 18 September 2026 under the framework of EU market abuse regulations. Over this five-day period, the company repurchased a total o...
Arkema Details September Share Buyback Transactions on Euronext Paris
Arkema has disclosed a series of share buyback transactions carried out on the Euronext Paris exchange between 7 and 11 September 2026. Over this period, the group repurchased a total of 17,700 shares at a weighted average price of €58.3610, with dai...
Arkema Reports Early September Share Buybacks Under EU Market Rules
Arkema disclosed that it executed a series of share buybacks on the Euronext Paris market between 1 and 4 September 2026. Over these four sessions the company repurchased a total of 12,800 shares of its own stock, with a weighted average acquisition...
Arkema Details August Share Buybacks on Euronext Paris
Arkema disclosed recent share buyback activity on Euronext Paris, repurchasing a total of 9,600 shares between 24 and 25 August 2026 at a daily weighted average price of about €59 per share. The transactions, carried out under EU market abuse regulat...
Arkema Buys Back 25,000 Shares on Paris Market Under Ongoing Program
Arkema disclosed that it repurchased 25,000 of its own shares on the Paris market between 17 and 21 August 2026, at a weighted average price of €60.12 per share, in accordance with European market abuse regulations. The buybacks form part of the grou...
Arkema details August share buybacks on Euronext Paris
Arkema has disclosed a new series of share buyback transactions conducted on the Euronext Paris market between August 10 and August 14, 2026, in line with European market-abuse regulations. Over the period, the group repurchased a total of 17,900 sha...
Arkema Repurchases 17,500 Shares in August Buyback Tranche
Arkema has reported a new series of share buybacks conducted between 3 and 7 August 2026 on the Paris market, repurchasing a total of 17,500 shares at a weighted average price of €61.27. The transactions, executed under the European market abuse regu...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026
